SIBO, or Small Intestinal Bacterial Overgrowth, refers to an excessive proliferation of bacteria in the small intestine. It is a disease that has only recently been registered in the international register of diseases as a sub-category of irritable bowel syndrome, and is still very little known in France (though much less so in the US, […]
What is the SIBO? Lire la suite »
SIBO (Small Intestinal Bacterial Overgrowth) is a digestive disorder that is increasingly being diagnosed. In France, Coligenta, an antibiotic based on colistin and gentamicin, is often prescribed to treat it. However, rifaximin, another antibiotic, benefits from a far greater number of clinical studies and a more reassuring safety profile. Given this situation, it is crucial
Coligenta vs Rifaximin for SIBO: an informed choice? Lire la suite »
